X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene

Journal of Medical Genetics

Volumn 43, Issue 8, 2006, Pages 699-704

  Jalkanen, R ^b   Manlyjarvi M ^c   Tobias, R ^d   Isosomppi, J ^a   Sankila, E M ^b   Alitalo, T ^b   Bech Hansen, N T ^d  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CACNA1F GENE; CONTROLLED STUDY; DNA SEQUENCE; ELECTROENCEPHALOGRAPHY; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; PRIORITY JOURNAL; RETINA DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; X LINKED CONE ROD DYSTROPHY;

ADULT; CALCIUM CHANNELS, L-TYPE; CASE-CONTROL STUDIES; CHILD; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; MALE; MUTATION; RETINITIS PIGMENTOSA; RNA, MESSENGER;

EID: 33747047272     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.040741     Document Type: Article

References (51)

1. Brown J Jr, Kimura AE, Gorin MB. Clinical and electroretinographic findings of female carriers and affected males in a progressive X-linked cone-rod dystrophy (COD-1) pedigree. Ophthalmology 2000;107:1104-10.
2. Jacobson DM, Thompson HS, Bartley JA. X-linked progressive cone dystrophy. Clinical characteristics of affected males and female carriers. Ophthalmology 1989;96:885-95.
3. Pinckers A, Timmerman GJMEN. Sex-difference in progressive cone dystrophy I. Ophthalmic Paediatr Genet 1981;1:17-23.
4. Meire FM, Bergen AA, De Rouck A, Leys M, Delleman JW. X linked progressive cone dystrophy. Localisation of the gene locus to Xp21-p11.1 by linkage analysis. Br J Ophthalmol 1994;78:103-8.
5. Hong HK, Ferrell RE, Gorin MB. Clinical diversity and chromosomal localization of X-linked cone dystrophy (COD1). Am J Hum Genet 1994;55:1173-81.
6. Mäntyjärvi M, Nurmenniemi P, Partanen J, Myöhänen T, Peippo M, Alitalo T. Clinical features and a follow-up study in a family with X-linked progressive cone-rod dystrophy. Acta Ophthalmol Scand 2001;79:359-05.
7. Heckenlively JR, Weleber RG. X-linked recessive cone dystrophy with tapetal-like sheen. A newly recognized entity with Mizuo-Nakamura phenomenon. Arch Ophthalmol 1986;104:1322-8.
8. Demirci FY, Rigatti BW, Wen G, Radak AL, Mah TS, Baic CL, Traboulsi EI, Alitalo T, Ramser J, Gorin MB. X-linked cone-rod dystrophy (locus COD1): identification of mutations in RPGR exon ORF15. Am J Hum Genet 2002;70:1049-53.
9. Meindl A, Dry K, Herrmann K, Manson F, Ciccodicola A, Edgar A, Carvalho MR, Achatz H, Hellebrand H, Lennon A, Migliaccio C, Porter K, Zrenner E, Bird A, Jay M, Lorenz B, Wittwer B, D'Urso M, Meitinger T, Wright A. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet 1996;13:35-42.
10. Yang Z, Peachey NS, Moshfeghi DM, Thirumalaichary S, Chorich L, Shugart YY, Fan K, Zhang K. Mutations in the RPGR gene cause X-linked cone dystrophy. Hum Mol Genet 2002;11:005-11.
11. Ayyagari R, Demirci FY, Liu J, Bingham EL, Stringham H, Kakuk LE, Boehnke M, Gorin MB, Richards JE, Sieving PA. X-linked recessive atrophic macular degeneration from RPGR mutation. Genomics 2002;80:160-71.
12. Bergen AA, Pinckers AJ. Localization of a novel X-linked progressive cone dystrophy gene to Xq27: evidence for genetic heterogeneity. Am J Hum Genet 1997;60:1468-73.
13. Jalkanen R, Demirci FY, Tyynismaa H, Bech-Hansen T, Meindl A, Peippo M, Mäntyjärvi M, Gorin MB, Alitalo T. A new genetic locus for X linked progressive cone-rod dystrophy. J Med Genet 2003;40:418-23.
14. Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T. Congenital stationary night blindness with negative electroretinogram. A new classification. Arch Ophthalmol 1986;104:1013-20.
15. Boycott KM, Pearce WG, Bech-Hansen NT. Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a rounder mutation in CACNA1F. Can J Ophthalmol 2000;35:204-13.
16. Pearce WG, Reedyk M, Coupland SG. Variable expressivity in X-linked congenital stationary night blindness. Can J Ophthalmol 1990;25:3-10.
17. Musarella MA, Weleber RG, Murphey WH, Young RS, Anson-Cartwright L, Mets M, Kraft SP, Polemeno R, Litt M, Worton RG. Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3. Genomics 1989;5:727-37.
18. Tremblay F, Laroche RG, De Becker I. The electroretinographic diagnosis of the incomplete form of congenital stationary night blindness. Vision Res 1995;35:2383-93.
19. Allen LE, Zito I, Bradshaw K, Patel PJ, Bird AC, Fitzke F, Yates JR, Trump D, Hardcastle AJ, Moore AT. Genotype-phenotype correlation in British families with X linked congenital stationary night blindness. Br J Ophthalmol 2003;87:1413-20.
20. Miyake Y, Horiguchi M, Terasaki H, Kondo M. Scotopic threshold response in complete and incomplete types of congenital stationary night blindness. Invest Ophthalmol Vis Sci 1994;35:3770-5.
21. Bech-Hansen NT, Naylor MJ, Maybaum TA, Sparkes RL, Koop B, Birch DG, Bergen AA, Prinsen CF, Polomeno RC, Gal A, Drack AV, Musarella MA, Jacobson SG, Young RS, Weleber RG. Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. Nat Genet 2000;26:319-23.
22. Pusch CM, Zeitz C, Brandau O, Pesch K, Achatz H, Feil S, Scharfe C, Maurer J, Jacobi FK, Pinckers A, Andreasson S, Hardcastle A, Wissinger B, Berger W, Meindl A. The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet 2000;26:324-7.
23. Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet 1998;19:264-7.
24. Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wulz K, Gulwillinger N, Ruther K, Drescher B, Sauer C, Zrenner E, Meitinger T, Rosenthal A, Meindl A. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet 1998;19:260-3.
25. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 2000;16:521-55.
26. Morgans CW. Localization of the alpha(1F) calcium channel subunit in the rat retina. Invest Ophthalmol Vis Sci 2001;42:2414-8.
27. Xu HP, Zhao JW, Yang XL. Expression of voltage-dependent calcium channel subunits in the rat retina. Neurosci Lett 2002;329:297-300.
28. Koschak A, Reimer D, Walter D, Hoda JC, Heinzle T, Grabner M, Striessnig J. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation. J Neurosci 2003;23:6041-9.
29. McRory JE, Hamid J, Doering CJ, Garcia E, Parker R, Hamming K, Chen L, Hildebrand M, Beedle AM, Feldcamp L, Zamponi GW, Snutch TP. The CACNA1F gene encodes an L-type calcium channel with unique biophysical properties and tissue distribution. J Neurosci 2004;24:1707-18.
30. Kotturi MF, Carlow DA, Lee JC, Ziltener HJ, Jefferies WA. Identification and functional characterization of voltage-dependent calcium channels in T lymphocytes. J Biol Chem 2003;278:46949-60.
31. Boycott KM, Maybaum TA, Naylor MJ, Weleber RG, Robitaille J, Miyake Y, Bergen AA, Pierpont ME, Pearce WG, Bech-Hansen NT. A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants. Hum Genet 2001;108:91-7.
32. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 1991;196:80-3.
33. Hoda JC, Zaghetto F, Koschak A, Striessnig J. Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Cav1.4 L-type Ca2+ channels. J Neurosci 2005;25:252-9.
34. Hemara-Wahanui A, Berjukow S, Hope CI, Dearden PK, Wu SB, Wilson-Wheeler J, Sharp DM, Lundon-Treweek P, Clover GM, Hoda JC, Striessnig J, Marksteiner R, Hering S, Maw MA. A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proc Natl Acad Sci U S A 2005;102:7553-8.
35. Yu AS, Hebert SC, Brenner BM, Lytton J. Molecular characterization and nephron distribution of a family or transcripts encoding the pore-forming subunit of Ca2+ channels in the kidney. Proc Natl Acad Sci U S A 1992;89:10494-8.
36. Safa P, Boulter J, Hales TG. Functional properties of Cav1.3 (alpha1D) L-type Ca2+ channel splice variants expressed by rat brain and neuroendocrine GH3 cells. J Biol Chem 2001;276:38727-37.
37. Perez-Reyes E, Wei XY, Castellano A, Birnbaumer L. Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes. J Biol Chem 1990;265:20430-6.
38. Barry EL, Gesek FA, Froehner SC, Friedman PA. Multiple calcium channel transcripts in rat osteosarcoma cells: selective activation of alpha 1D isoform by parathyroid hormone. Proc Natl Acad Sci U S A 1995;92:10914-8.
39. Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT, Soong TW. Transcript scanning reveals novel and extensive splice variations in human I-type voltage-gated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem 2004;279:44335-43.
40. Jacobi FK, Hamel CP, Arnaud B, Blin N, Broghammer M, Jacobi PC, Apfelstedt-Sylla E, Pusch CM. A novel CACNA1F mutation in a French family with the incomplete type of X-linked congenital stationary night blindness. Am J Ophthalmol 2003;135:733-6.
41. Nakamura M, Ito S, Terasaki H, Miyake Y. Novel CACNA1F mutations in Japanese patients with incomplete congenital stationary night blindness. Invest Ophthalmol Vis Sci 2001;42:1610-6,
42. Wutz K, Sauer C, Zrenner E, Lorenz B, Alitalo T, Broghammer M, Hergersberg M, de la Chapelle A, Weber BH, Wissinger B, Meindl A, Pusch CM. Thirty distinct CACNA1F mutations in 33 families with incomplete type of XLCSNB and Cacna1f expression profiling in mouse retina. Eur J Hum Genet 2002;10:449-56.
43. Zeitz C, Minotti R, Feil S, Matyas G, Cremers FP, Hoyng CB, Berger W. Novel mutations in CACNA1F and NYX in Dutch families with X-linked congenital stationary night blindness. Mol Vis 2005;11:179-83.
44. Zito I, Allen LE, Patel RJ, Meindl A, Bradshaw K, Yates JR, Bird AC, Erskine L, Cheetham ME, Webster AR, Poopalasundaram S, Moore AT, Trump D, Hardcastle AJ. Mutations in the CACNA1F and NYX genes in British CSNBX families. Hum Mutat 2003;21:169.
45. Carlson S, Vesti E, Raitta C, Donner M, Eriksson AW, Forsius H. Clinical and eledroretinographic comparison between Aland Island eye disease and a newly found related disease with X-chromosomal inheritance. Acta Ophthalmol (Copenh) 1991;69:703-10.
46. Nakamura M, Ito S, Terasaki H, Miyake Y. Incomplete congenital stationary night blindness associated with symmetrical retinal atrophy. Am J Ophthalmol 2002;134:463-5.
47. Nakamura M, Ito S, Piao CH, Terasaki H, Miyake Y. Retinal and optic disc atrophy associated with a CACNA1F mutation in a Japanese family. Arch Ophthalmol 2003;121:1028-33.
48. Hope CI, Sharp DM, Hemara-Wahanui A, Sissingh JI, Lundon P, Mitchell EA, Maw MA, Clover GM. Clinical manifestations of a unique X-linked retinal disorder in a large New Zealand family with a novel mutation in CACNA1F, the gene responsible for CSNB2. Clin Experiment Ophthalmol 2005;33:129-36.
49. Langrova H, Gamer D, Friedburg C, Besch D, Zrenner E, Apfelstedt-Sylla E. Abnormalities of the long flash ERG in congenital stationary night blindness of the Schubert-Bornschein type. Vision Res 2002;42:1475-83.
50. Kellner U, Foerster MH. Cone dystrophies with negative photopic eledroretinogram. Br J Ophthalmol 1993;77:404-9.
51. Mansergh F, Orton NC, Vessey JP, Lalonde MR, Stell WK, Tremblay F, Barnes S, Rancourt DE, Bech-Hansen NT. Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synoptic transmission and cellular organization in mouse retina. Hum Mol Genet 2005;14:3035-46.